Vegf polymorphisms and anti-angiogenesis therapy

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01)

Patent

CA 2705792

Methods for determining whether a patient in at particular risk of hypertension associated with anti-VEGF treatment or has a greater likelihood of benefiting from anti-VEGF therapy by screening a sample isolated from the patient for specific genomic polymorphisms.

La présente invention concerne des procédés pour déterminer si un patient a un risque particulier de développer une hypertension associée à un traitement anti-VEGF ou s'il a une probabilité plus importante de bénéficier d'une thérapie anti-VEGF en criblant un échantillon isolé du patient pour des polymorphismes génomiques spécifiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vegf polymorphisms and anti-angiogenesis therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vegf polymorphisms and anti-angiogenesis therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vegf polymorphisms and anti-angiogenesis therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436787

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.